Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Uy Ear's Stock Ratings
Mizuho Analyst
Uy Ear is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
17.5%
Smart Score
Overall Average Return Percentile
73rd
Number of Ratings
87
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/12/2025 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | 14.39% | $146 → $175 | Maintains | Neutral | Get Alert | |
| 12/09/2025 | QURE | Buy Now | uniQure | $19.89 | 65.91% | $60 → $33 | Maintains | Outperform | Get Alert | |
| 12/02/2025 | EOLS | Buy Now | Evolus | $7.18 | 164.62% | $20 → $19 | Maintains | Outperform | Get Alert | |
| 12/02/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | 7.59% | $24 → $29 | Maintains | Neutral | Get Alert | |
| 11/28/2025 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | 26.97% | $32 → $37 | Maintains | Outperform | Get Alert | |
| 11/19/2025 | RLMD | Buy Now | Relmada Therapeutics | $4.07 | 145.7% | $1 → $10 | Upgrade | Neutral → Outperform | Get Alert | |
| 11/05/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 22.18% | $19 → $26 | Upgrade | Neutral → Outperform | Get Alert | |
| 10/27/2025 | ALKS | Buy Now | Alkermes | $28.10 | 60.14% | $40 → $45 | Maintains | Outperform | Get Alert | |
| 09/25/2025 | QURE | Buy Now | uniQure | $19.89 | 201.66% | $30 → $60 | Maintains | Outperform | Get Alert | |
| 09/24/2025 | MBX | Buy Now | MBX Biosciences | $28.54 | 96.22% | $38 → $56 | Maintains | Outperform | Get Alert | |
| 08/07/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -10.96% | $23 → $24 | Maintains | Neutral | Get Alert | |
| 08/05/2025 | MBX | Buy Now | MBX Biosciences | $28.54 | 33.15% | → $38 | Initiates | → Outperform | Get Alert | |
| 07/21/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | -34.21% | $40 → $14 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/18/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 87.97% | $85 → $40 | Maintains | Outperform | Get Alert | |
| 05/19/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -14.67% | $20 → $23 | Maintains | Neutral | Get Alert | |
| 05/15/2025 | TECX | Buy Now | Tectonic Therapeutic | $19.10 | 345.03% | $51 → $85 | Maintains | Outperform | Get Alert | |
| 05/09/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 299.43% | $179 → $85 | Maintains | Outperform | Get Alert | |
| 04/21/2025 | TECX | Buy Now | Tectonic Therapeutic | $19.10 | 167.02% | → $51 | Initiates | → Outperform | Get Alert | |
| 02/26/2025 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -27.93% | $20 → $21 | Maintains | Outperform | Get Alert | |
| 01/07/2025 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -31.37% | $19 → $20 | Maintains | Outperform | Get Alert | |
| 12/19/2024 | QURE | Buy Now | uniQure | $19.89 | 0.55% | $7 → $20 | Maintains | Neutral | Get Alert | |
| 12/05/2024 | RLMD | Buy Now | Relmada Therapeutics | $4.07 | -75.43% | $23 → $1 | Downgrade | Outperform → Neutral | Get Alert | |
| 11/13/2024 | ALKS | Buy Now | Alkermes | $28.10 | 42.35% | $35 → $40 | Maintains | Outperform | Get Alert | |
| 08/07/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -25.8% | $21 → $20 | Maintains | Neutral | Get Alert | |
| 07/19/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $18 → $16 | Maintains | Neutral | Get Alert | |
| 05/24/2024 | RNAC | Buy Now | Cartesian Therapeutics | $8.52 | 369.48% | → $40 | Initiates | → Buy | Get Alert | |
| 05/17/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 741.16% | $145 → $179 | Maintains | Buy | Get Alert | |
| 05/15/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -38.23% | $17 → $18 | Maintains | Buy | Get Alert | |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -22.09% | $25 → $21 | Maintains | Neutral | Get Alert | |
| 05/08/2024 | QURE | Buy Now | uniQure | $19.89 | -69.83% | $7 → $6 | Maintains | Neutral | Get Alert | |
| 04/26/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $20 → $18 | Maintains | Neutral | Get Alert | |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -7.25% | $39 → $25 | Downgrade | Buy → Neutral | Get Alert | |
| 03/08/2024 | EOLS | Buy Now | Evolus | $7.18 | 220.33% | $20 → $23 | Maintains | Buy | Get Alert | |
| 03/04/2024 | QURE | Buy Now | uniQure | $19.89 | -64.81% | $10 → $7 | Maintains | Neutral | Get Alert | |
| 02/28/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -41.66% | $16 → $17 | Reiterates | Buy → Buy | Get Alert | |
| 02/28/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | 44.69% | $40 → $39 | Maintains | Buy | Get Alert | |
| 02/23/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -45.09% | $8 → $16 | Reiterates | Buy → Buy | Get Alert | |
| 02/14/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 581.38% | $130 → $145 | Maintains | Buy | Get Alert | |
| 02/08/2024 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -8.49% | $116 → $140 | Maintains | Neutral | Get Alert | |
| 01/03/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -72.55% | $4 → $8 | Upgrade | Neutral → Buy | Get Alert | |
| 01/02/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -72.55% | $4 → $8 | Upgrade | Neutral → Buy | Get Alert | |
| 12/29/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | 48.4% | $35 → $40 | Maintains | Buy | Get Alert | |
| 12/19/2023 | QURE | Buy Now | uniQure | $19.89 | -49.72% | → $10 | Downgrade | Buy → Neutral | Get Alert | |
| 12/18/2023 | AVRO | Buy Now | Avrobio | — | — | $5 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 11/22/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | $35 → $16 | Maintains | Buy | Get Alert | |
| 11/10/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -25.48% | $116 → $114 | Maintains | Neutral | Get Alert | |
| 11/06/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | 29.85% | $20 → $35 | Upgrade | Neutral → Buy | Get Alert | |
| 11/03/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -24.18% | $113 → $116 | Maintains | Neutral | Get Alert | |
| 10/27/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | -86.27% | $57 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 10/26/2023 | ALKS | Buy Now | Alkermes | $28.10 | 24.56% | $37 → $35 | Maintains | Buy | Get Alert | |
| 09/26/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 651.87% | → $160 | Reiterates | Buy → Buy | Get Alert | |
| 09/25/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | 95.61% | → $57 | Reiterates | Buy → Buy | Get Alert | |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -26.14% | → $113 | Reiterates | Neutral → Neutral | Get Alert | |
| 08/18/2023 | SELB | Buy Now | Selecta Biosciences | — | — | $4 → $3 | Maintains | Buy | Get Alert | |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -26.79% | $111 → $112 | Maintains | Neutral | Get Alert | |
| 06/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -25.8% | $20 → $20 | Reiterates | Neutral → Neutral | Get Alert | |
| 06/12/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | 95.61% | → $57 | Reiterates | Buy → Buy | Get Alert | |
| 06/07/2023 | EOLS | Buy Now | Evolus | $7.18 | 178.55% | $17 → $20 | Maintains | Buy | Get Alert | |
| 06/07/2023 | JNJ | Buy Now | Johnson & Johnson | $214.05 | -81.31% | $36 → $40 | Maintains | Buy | Get Alert | |
| 05/10/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | 95.61% | $61 → $57 | Maintains | Buy | Get Alert | |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -27.44% | $116 → $111 | Maintains | Neutral | Get Alert | |
| 04/27/2023 | ALKS | Buy Now | Alkermes | $28.10 | 28.11% | $37 → $36 | Maintains | Buy | Get Alert | |
| 04/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -25.8% | $20 → $20 | Reiterates | Neutral → Neutral | Get Alert | |
| 04/14/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 651.87% | → $160 | Reiterates | → Buy | Get Alert | |
| 04/14/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -24.18% | → $116 | Reiterates | → Neutral | Get Alert | |
| 04/11/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | 109.33% | → $61 | Reiterates | → Buy | Get Alert | |
| 04/11/2023 | ALKS | Buy Now | Alkermes | $28.10 | 31.67% | $36 → $37 | Maintains | Buy | Get Alert | |
| 03/30/2023 | STSA | Buy Now | Satsuma Pharma | — | — | → $2 | Reiterates | → Neutral | Get Alert | |
| 03/24/2023 | AVRO | Buy Now | Avrobio | — | — | $6 → $5 | Maintains | Buy | Get Alert | |
| 03/22/2023 | SELB | Buy Now | Selecta Biosciences | — | — | $5 → $4 | Maintains | Buy | Get Alert | |
| 03/17/2023 | CABA | Buy Now | Cabaletta Bio | $2.42 | 312.37% | → $10 | Reiterates | → Buy | Get Alert | |
| 03/17/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.28 | 651.87% | → $160 | Reiterates | → Buy | Get Alert | |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -25.8% | $19 → $20 | Maintains | Neutral | Get Alert | |
| 03/13/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -29.51% | $19 → $19 | Reiterates | Neutral → Neutral | Get Alert | |
| 03/01/2023 | OCGN | Buy Now | Ocugen | $1.42 | 112.01% | $5 → $3 | Maintains | Buy | Get Alert | |
| 02/28/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -29.51% | $15 → $19 | Maintains | Neutral | Get Alert | |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -24.18% | → $116 | Maintains | Neutral | Get Alert | |
| 01/19/2023 | EOLS | Buy Now | Evolus | $7.18 | 136.77% | $15 → $17 | Maintains | Buy | Get Alert | |
| 12/21/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.95 | -44.35% | $17 → $15 | Maintains | Neutral | Get Alert | |
| 11/22/2022 | ALKS | Buy Now | Alkermes | $28.10 | 28.11% | $34 → $36 | Maintains | Buy | Get Alert | |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -24.18% | $105 → $116 | Maintains | Neutral | Get Alert | |
| 10/20/2022 | NBIX | Buy Now | Neurocrine Biosciences | $152.99 | -31.37% | $98 → $105 | Maintains | Neutral | Get Alert | |
| 08/23/2022 | OCGN | Buy Now | Ocugen | $1.42 | 253.36% | → $5 | Initiates | → Buy | Get Alert | |
| 04/07/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | 95.61% | $58 → $57 | Maintains | Buy | Get Alert | |
| 01/06/2022 | AVRO | Buy Now | Avrobio | — | — | $28 → $6 | Maintains | Buy | Get Alert | |
| 06/30/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.14 | 99.04% | → $58 | Initiates | → Buy | Get Alert | |
| 06/27/2019 | AVRO | Buy Now | Avrobio | — | — | → $28 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved